OncoTree Code was selected to indicate the ratio of cancer patients with/without genetic alterations in ESR1, ESR2, and PGR (Figure 7B), and results suggested the potentially critical roles of ESR1, ESR2 and PGR in onset of multiple cancers. This evidence concerns the gene ESR2 and cancer.